QIZ is a Q1 success

From its establishment mid-February 2005, the number of participating Egyptian factories has grown 15% to 100.

By AVI KRAWITZ
May 23, 2006 08:41

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Israeli exports to Egyptian factories in the Qualified Industrial Zone between the two countries reached $14 million in the first quarter, the Ministry of Industry, Trade and Labor said Monday, following deliberations of the joint QIZ committee in Cairo this week. The QIZ agreement, which allow Egypt to sell merchandise to the US with duty and tax reductions as long as they include an Israeli component, boosted Egyptian exports to the US for the quarter to $120m., the ministry reported, while exports for the full year 2005 stood at $500m. From its establishment mid-February 2005, the number of participating Egyptian factories has grown 15% to 100.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS